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Abstract: Implants formed of metals, bioceramics, or polymers may provide an alternative 
to autografts for treating large bone defects. However, limitations to each material motivate 
the examination of composites to capitalize on the beneficial aspects of individual 
components and to address the need for conferring bioactive behavior to the polymer 
matrix. We hypothesized that the inclusion of different bioceramics in a ceramic-polymer 
composite would alter the physical properties of the implant and the cellular osteogenic 
response. To test this, composite scaffolds formed from poly(lactide-co-glycolide) (PLG) 
and either hydroxyapatite (HA), β-tricalcium phosphate (TCP), or bioactive glass (Bioglass 
45S®, BG) were fabricated, and the physical properties of each scaffold were examined. 
We quantified cell proliferation by DNA content, osteogenic response of human 
osteoblasts (NHOsts) to composite scaffolds by alkaline phosphatase (ALP) activity, and 
changes in gene expression by qPCR. Compared to BG-PLG scaffolds, HA-PLG and  
TCP-PLG composite scaffolds possessed greater compressive moduli. NHOsts on BG-PLG 
substrates exhibited higher ALP activity than those on control, HA-, or TCP-PLG scaffolds 
after 21 days, and cells on composites exhibited a 3-fold increase in ALP activity between 
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7 and 21 days versus a minimal increase on control scaffolds. Compared to cells on PLG 
controls, RUNX2 expression in NHOsts on composite scaffolds was lower at both 7 and  
21 days, while expression of genes encoding for bone matrix proteins (COL1A1 and 
SPARC) was higher on BG-PLG scaffolds at both time points. These data demonstrate the 
importance of selecting a ceramic when fabricating composites applied for bone healing. 
Keywords: bioceramic; hydroxyapatite; bioactive glass; composite; scaffold; bone 
 
1. Introduction  
The treatment of slow or nonhealing bone fractures is a significant clinical problem. Implants 
formed of metals, bioceramics, polymers, and decellularized tissues are under investigation to reduce 
or eliminate the current limitations of the “gold standard” of autograft bone. However, each of these 
materials also presents challenges in their application including wear debris formation and stress 
shielding, inadequate porosity to allow cellular infiltration, inability to be resorbed, or undesirable 
inflammatory responses [1]. Moreover, with the exception of polymeric systems, significant challenges 
exist to tailor these implants for the specific defect requiring treatment. 
Calcium phosphate ceramics and bioactive glasses share similarities between their surface 
composition and chemical structure and the mineral phase of bone, and demonstrate enhanced 
osteoconductivity under in vivo settings [2]. Hydroxyapatite (HA; Ca10(PO4)6(OH)2) is the major 
mineral component of bone and is widely used as a bone substitute, both as a homogeneous implant 
and as a component of composite materials [3]. Βeta-tricalcium phosphate (β-TCP; Ca3(PO4)2) shares 
similar chemical composition as HA, but resorbs faster due to its lower Ca/P ratio and is weaker than 
HA per unit mass, making its use in treating defects in load-bearing bones more challenging [4]. 
Bioactive glasses (BG) exhibit tissue stimulatory properties and are under extensive investigation for 
their potential use in engineering of hard tissues [5,6]. However, the formation of implants which are 
wholly composed of bioceramics requires high temperatures, controlled cooling, and the resulting 
materials are brittle and slowly resorbable [7].  
The development of matrices that possess sufficient strength, osteoconductivity, porosity, and 
degradation times represents a major focus in the arena of bone repair. Polymers derived from 
synthetic materials are commonly biocompatible, bioresorbable, and tailorable materials that can be 
molded into highly porous scaffolds [8]. For example, poly(lactide-co-glycolide) (PLG) is a 
commonly-used polymer for bridging bone tissue defects due to the ease of tailoring the degradation 
time by modulating the ratio of lactide and glycolide monomers during synthesis [9,10]. However, 
scaffolds formed of PLG lack sufficient mechanical strength for withstanding load, desirable 
osteoconductivity for integration with surrounding bone, or fail to provide instructional cues to  
the resident cells [11]. Moreover, there is a pressing need for conferring bioactive behavior to the 
polymer matrix. 
In response to limitations of implants formed solely of bioceramics and polymers, we and others 
have developed composite scaffolds to capitalize on the beneficial aspects of the individual 
components. Polymers reinforced with bioceramics, fabricated using a variety of methods, consistently 
J. Funct. Biomater. 2012, 3 384 
 
 
demonstrate improved mechanical properties over polymeric substrates without the constraints required 
of producing 3D bioceramic implants. The osteoconductivity and osteogenic potential of polymers is 
increased upon the addition of ceramics such as bone-like mineral, HA, TCP, and BG [12–16]. 
Composite scaffolds can have profound effects on other aspects of bone repair beyond inducing 
osteogenic differentiation. For example, we demonstrated that scaffolds containing nanosized HA 
enhance the osteogenic response and upregulate the secretion of potent proangiogenic trophic factors 
from human mesenchymal stem cells, thereby increasing the persistence of implanted cells, 
accelerating neovascularization, and enhancing bone formation [17,18]. BG stimulates angiogenesis  
in vivo [6,19], and vessel density and the quality of new bone formation was increased in calvarial 
defects treated with BG-coated scaffolds [20]. 
Despite significant evidence demonstrating the efficacy of bioceramic-polymer composite scaffolds 
for bone formation, little is known regarding potential differences in osteogenesis using composite 
scaffolds containing differing bioceramic particulates. We hypothesized that the identity of the ceramic 
incorporated within macroporous polymer scaffold composites would contribute to its material properties 
and osteogenic potential. In this study, composite scaffolds were fabricated using three common calcium 
phosphate materials: HA, TCP, or BG. We report that the addition of any bioceramic increases scaffold 
stiffness, decreases porosity, and differentially directs osteogenesis of NHOsts, with BG-loaded scaffolds 
potently stimulating osteogenesis compared to scaffolds containing other bioceramics.  
2. Experimental Section  
2.1. Scaffold Preparation 
Scaffolds were prepared using a gas foaming/particulate leaching method as described [18,21]. 
Briefly, PLG microspheres (85:15 DLG 7E; Lakeshore Biomaterials, Birmingham, AL, USA) were 
prepared using a double emulsion process. Bioceramic particulate, lyophilized microspheres, and NaCl 
particles (250–425 µm in diameter) were mixed in a 2.5:1:19 ratio, while control scaffolds were 
prepared without bioceramic. The selection of mass ratio was derived from our previous studies 
demonstrating increased stiffness while maintaining porosity in macroporous scaffolds at this mass 
ratio [18]. Composite scaffolds were fabricated using hydroxyapatite (HA, 100 nm diameter; Berkeley 
Advanced Biomaterials, Berkeley, CA, USA), β-tricalcium phosphate (TCP, <200 nm particle size, 
Sigma Aldrich, St. Louis, MO, USA), or 45S5 Bioglass® (BG, 90–170 μm particle size, Novabone, 
Alachua, FL, USA). Mixtures were compressed in a stainless steel die using a Carver Press (Fred S. 
Carver) at 10 MPa for 1 min to produce solid disks (8.5 mm diameter, 1.5 mm thick). Disks were then 
placed under high pressure CO2 gas (5.5 MPa) for 16 h, after which the pressure was rapidly released 
to ambient to achieve polymer fusion. Solid disks were leached in distilled water for 24 h to remove 
the NaCl particles and generate highly porous scaffolds.  
2.2. Scaffold Characterization 
Gross morphology of scaffolds was determined by scanning electron microscope images. Scaffolds 
were gold-coated using a sputter coater (Desk II; Denton Vacuum, Moorestown, NJ, USA). Specimens 
were imaged with a Hitachi S3500-N Scanning Electron Microscope at 10 kV. Pore diameter was 
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quantified from scanning electron microscope images by measuring the long-axis of 20–40 pores in 
each scaffold using NIH Image J. Scaffold porosity was determined using Archimedes’ method [18]. 
Scaffolds were submerged in 100% EtOH in a custom-made vacuum bottle for 5 min until all bubbles 
were removed from the pores. The weight of the scaffolds before and after immersion was recorded, 
and scaffold porosity was calculated.  
The distribution of bioceramic particulate throughout the scaffolds was grossly observed by 
adsorption of Trypan blue as described [18,22]. Scaffolds were exposed to a 0.4% (w/v) Trypan blue 
solution (Alfa Aesar, Ward Hill, MA, USA) for 10 s. Scaffolds were rinsed twice in distilled H2O and 
placed in 100% EtOH for 1 min. Scaffolds were sonicated for 5 s at 40% power in 100% EtOH to 
remove remaining unbound dye and rinsed in distilled H2O before drying and analysis. The efficiency 
of bioceramic incorporation was determined by measuring the mass of individual components and final 
scaffold mass after fabrication. 
Scaffold stiffness was determined by measuring the compressive modulus using an Instron 5,800 
Series Testing System (Norwood, CA, USA). Samples were compressed with a constant deformation 
rate of 1 mm/min. The compressive modulus was calculated from the first 5% of the strain [18]. 
2.3. Cell Culture 
Normal human osteoblasts (NHOsts) were purchased from Lonza (Clonetics®, Walkersville, MD, 
USA). NHOsts were expanded in DMEM (Invitrogen, Carlsbad, CA, USA) containing 10% fetal 
bovine serum (FBS, JR Scientific, Woodland, CA, USA) and 1% penicillin/streptomycin (Mediatech, 
Manassas, VA, USA) in standard cell culture conditions (37 °C, 5% CO2, 21% O2). Experiments were 
performed with cells between passages 2–5. 
2.4. Osteogenic Potential 
Scaffolds were sterilized in 95% EtOH for 30 min, rinsed twice with sterile PBS over 30 min, 
and incubated in DMEM for 30 min prior to cell seeding. NHOsts were statically seeded at  
7.5 × 106 cells/cm3 and allowed to attach for 1 h before moving cell-seeded constructs into DMEM. On 
day 0 (24 h post cell seeding), media was exchanged for fresh DMEM containing osteogenic 
supplements composed of 10 mM β-glycerophosphate and 50 µg/mL ascorbate-2-phosphate. Scaffolds 
were maintained under standard cell culture conditions on an XYZ shaker to enhance transport within 
the 3D construct, and media was changed every 3–4 days. 
Samples were collected and analyzed after 4 h to assess cell seeding efficiency, or after 7 or 21 days 
to determine osteogenic potential. Briefly, scaffolds were rinsed in PBS and minced with a razor blade, 
incubated in 1X passive lysis buffer (Promega, San Luis Obispo, CA, USA) at room temperature for 
10 min, sonicated briefly, and centrifuged at 10,000 rpm for 5 min. The supernatant was assayed for 
alkaline phosphatase (ALP) activity by incubating with 50 mM p-nitrophenyl phosphate (PNPP) in an 
assay buffer (100 mM glycine, 1 mM MgCl2, pH = 10.5) at 37 °C [12,23]. Absorbance was 
measured at 405 nm and converted to ALP activity using the extinction coefficient for PNPP  
(1.85 × 104 M−1·cm−1). DNA content was quantified from lysate using a Quant-iT PicoGreen dsDNA 
kit (Invitrogen). To determine cell distribution, scaffolds were seeded with NHOsts and cultured for  
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1 day, decalcified in Calci-Clear (National Diagnostics, Atlanta, GA, USA) for 3 days, and 
hemotoxylin and eosin staining was performed on paraffin-embedded sections at 5 µm thickness. 
The expression of genes associated with osteogenesis was measured in NHOsts seeded on composite 
scaffolds using qPCR. Briefly, total RNA from scaffolds was collected using an RNeasy Mini kit 
(Qiagen, Valencia, CA, USA) at 7 and 21 days. Between 200–1,000 ng of total RNA was  
reverse-transcribed with Superscript II Reverse Transcriptase (Invitrogen). Quantitative PCR was 
performed using primers and probes for RUNX2, COL1A1, and SPARC (Applied Biosystems, Foster 
City, CA, USA) on a Mastercycler® realplex2 (Eppendorf, Westbury, NY, USA). Amplification 
conditions were 50 °C for 2 min, 95 °C for 10 min, followed by 40 cycles at 95 °C for 15 s and 60° C 
for 1 min. Quantitative PCR results were normalized to RPL13 transcript level to yield Ct. Fold 
change in expression was subsequently calculated using the formula 2−∆Ct [24]. 
2.5. Statistical Analysis 
Results are expressed as mean ± standard deviation (SD) of the mean, assuming normal distribution 
of data sets, with the exception of PCR data, which is expressed as mean ± standard error of the mean 
(SEM). Statistical analyses were performed between two groups using the Student’s t-test or between 
multiple groups using a one-way ANOVA with Student Newman-Keuls multiple comparison post hoc 
test in GraphPad Prism® 5 analysis software (GraphPad Software, San Diego, CA, USA). Probability 
values (p) for significance were calculated; p < 0.05 was considered statistically significant. 
3. Results and Discussion  
3.1. Scaffold Characterization 
Bioceramic incorporation in macroporous scaffolds was highly efficient, as we did not detect any 
measurable loss in weight after scaffold fabrication for any group. We observed similar pore diameters 
for each scaffold type when imaging cross-sections using scanning electron microscopy (Figure 1a). 
The edges of the pores appeared rougher and less defined in composite scaffolds compared to PLG 
control scaffolds. We observed homogenous distribution of bioceramic particulate throughout the 
scaffolds when qualitatively assessed by Trypan blue adsorption (Figure 1b). HA-containing scaffolds 
adsorbed more dye than other composites. Scaffolds stained uniformly, despite differences in intensity 
for the stain, thus confirming homogenous distribution of the bioceramic throughout the composite 
scaffold. Composite scaffolds exhibited significant reductions in porosity compared to control 
scaffolds (93.0 ± 1.7%; Figure 1c). However, composites formed with HA and TCP had similar 
porosities (82.4 ± 1.3% and 80.8 ± 5.3%), respectively, while scaffolds containing BG showed reduced 
porosity (64.2 ± 6.8%). Moreover, scaffolds formed with BG exhibited lower pore diameters  
compared to other substrates (Figure 1d), suggesting that the ceramic was not entirely embedded 
within the polymer. 
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Figure 1. (a) Construct morphology was observed using scanning electron microscopy. 
Substrates imaged at 100X; scale bar represents 200 µm; (b) The presence and distribution 
of bioceramic was qualitatively observed by Trypan blue staining; (c) Scaffold porosity 
was determined using Archimedes’ method; (d) Scaffold pore diameter from each scaffold 
formulation. Data are mean ± SD (n = 5 for a–c; n = 20–40 for (d)). *** p < 0.0001 vs. 
PLG; ** p < 0.001 vs. PLG; $ p < 0.05 vs. PLG; # p < 0.0001 vs. HA-PLG and TCP-PLG; 
% p < 0.001 vs. TCP-PLG. 
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Figure 1. Cont. 
 
(d) 
Compressive moduli increased upon the addition of any bioceramic. Composite scaffolds containing 
HA and TCP exhibited a 3–4 fold increase in compressive modulus compared to PLG scaffolds, while 
substrates containing BG exhibited a 2.5 fold greater compressive modulus, on average, versus control 
scaffolds (Figure 2).  
Figure 2. Influence of bioceramic on mechanical properties of substrate. Compressive 
modulus increased with the addition of bioceramic. Data are mean ± SD (n = 9 for PLG 
scaffolds, n = 5 for composite scaffolds). *** p < 0.0001 vs. PLG; ** p < 0.001 vs. PLG;  
# p < 0.05 vs. HA-PLG and TCP-PLG.  
 
3.2. Osteoconductive Potential of Composite Scaffolds 
Upon examination by hemotoxylin and eosin staining, cells appeared to adhere predominantly to 
the outer surface of the scaffold (Figure 3). There were no statistically significant differences in cell 
seeding efficiency (Figure 4a). The ability of each scaffold to support cell proliferation and survival 
was assessed by quantifying DNA content on each scaffold after 7 or 21 days in culture. After 21 days, 
DNA content per scaffold was reduced in scaffolds containing PLG, HA, or TCP (Figure 4b).  
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Figure 3. Distribution of cells on scaffolds observed by H&E staining. Images at 200× 
magnification (scale bar represents 100 µm).  
 
Figure 4. NHOst seeding efficiency (a) and proliferation (b) was measured by quantifying 
total DNA mass on 3D scaffolds. Data are mean ± SD (n = 4). * p < 0.05 vs. PLG control; 
*** p < 0.001 vs. PLG; †† p < 0.001 vs. BG-PLG; # p < 0.05 vs. TCP-PLG. 
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Figure 4. Cont. 
 
(b) 
3.3. Osteogenic Response of NHOsts 
Changes in ALP activity were monitored as an indicator of osteoblastic differentiation of NHOsts 
as a function of scaffold composition (Figure 5). At Day 7, cells on HA-containing scaffolds exhibited 
significantly decreased ALP activity compared to PLG scaffolds, while cells on PLG, TCP-PLG, and 
BG-PLG exhibited statistically similar levels of enzymatic activity. After 3 weeks of culture, NHOsts 
on BG-PLG demonstrated significantly increased ALP activity compared to all other groups, while the 
remaining groups induced similar ALP activity. ALP activity increased over the 3-week culture period 
for all scaffolds. However, cells on composite scaffolds exhibited a comparable 3–4-fold increase in 
enzyme activity, while cells on control scaffolds demonstrated only a marginal increase over 21 days. 
Figure 5. Alkaline phosphatase activity for NHOsts cultured on macroporous scaffolds. 
Data are mean ± SD (n = 4). *p < 0.05 vs. PLG at Day 7. **p < 0.01 vs. PLG, HA-PLG, 
and TCP-PLG at Day 21.  
 
 
The expression of osteogenic marker genes RUNX2, COL1A1, and SPARC was analyzed by qPCR 
from 3D cultures after 7 or 21 days of culture. RUNX2 is an obligate transcription factor for, and early 
indicator of, osteogenesis [25,26]. NHOsts on PLG control scaffolds exhibited greater RUNX2 
expression at both time points compared to cells on any composite scaffold (Figure 6a). Cells on  
HA- and TCP-containing scaffolds demonstrated significantly lower RUNX2 expression than cells on 
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control scaffolds at both time points. RUNX2 expression of cells seeded on HA-PLG scaffolds was 
significantly lower than cells on BG composite scaffolds at Day 7, while cells on TCP scaffolds 
expressed lower RUNX2 levels than those on BG composite scaffolds at Day 21. 
Figure 6. Quantitative PCR results for genes monitored in NHOsts over 3 weeks cultured 
on macroporous scaffolds: RUNX2 (a), COL1A1 (b), and SPARC (c). Values reflect fold 
change in the target mRNA expression over RPL13 vs. Day 7 PLG. Data are mean ± SEM 
(n = 4). * p < 0.05 vs. PLG control; ** p < 0.01 vs. PLG; *** p < 0.001 vs. PLG; # p < 0.05 
vs. HA-PLG; ## p < 0.001 vs. HA-PLG; $ p < 0.001 vs. TCP-PLG; † p < 0.05 vs. BG-PLG; 
†† p < 0.001 vs. BG-PLG. 
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Type I collagen is a major constituent of the organic matrix of bone, and COL1A1 encodes for two 
of the three fibrils that compose collagen I filaments [27]. The influence of substrate composition on 
COL1A1 transcript exhibited similar trends to RUNX2 expression (Figure 6b). Specifically, cells on 
BG-PLG scaffolds demonstrated greater COL1A1 expression versus all other composite scaffolds at 
Day 7, with cells on HA- and TCP-loaded scaffolds possessing significantly lower expression 
compared to PLG controls. After 21 days, NHOsts on BG-PLG scaffolds expressed significantly 
greater COL1A1 transcript compared to the other composite substrates, and cells on HA- and  
TCP-containing scaffolds behaved similar to that of 7 days. 
Osteonectin, encoded by the gene SPARC, is a bone-specific protein that is selectively bound to 
insolubilized type I collagen to enhance the complex binding of synthetic apatite crystals and free 
calcium ions, thus promoting the nucleation of mineral [28]. Thus, SPARC is a later marker of 
osteogenesis and signifies the onset of mature bone formation. SPARC gene expression profiles were 
similar to COL1A1 and remained relatively constant in all groups throughout the study period  
(Figure 6c). NHOsts on BG-PLG scaffolds exhibited significantly higher SPARC expression at both 7 
and 21 days, more than 4.3- and 5.2-fold, respectively, compared to remaining scaffolds.  
We sought to explore the contribution of individual bioceramics present within composite implants 
that are designed for applications in bone tissue engineering. Specifically, we aimed to determine if 
different ceramics would induce differences in physical properties when fabricating macroporous 
composite scaffolds, as well as the resulting osteogenic response of human osteoblasts. These data 
confirm that the resultant physical properties of composite scaffolds are dependent upon ceramic 
identity, while materials incorporated within osteoconductive bioceramic composite scaffolds 
differentially direct the behavior of normal human osteoblasts.  
Scaffolds that are designed for bridging bone defects and serving as successful cell carriers should 
ideally be highly porous in order to facilitate cellular invasion and host neovascularization, enable 
efficient transport of nutrients and waste removal to support cell survival, and promote integration with 
surrounding bone. The composition of such composite scaffolds is a critical mediator for material 
properties and cellular response. We fabricated scaffolds with a constant 2.5:1 mass ratio of ceramic to 
polymer based on our previously published studies that confirmed robust osteogenic response of 
human mesenchymal stem cells while maintaining high scaffold porosity [18]. Moreover, the 
compressive moduli of all composite scaffolds were within the lower limit of the compressive strength 
of trabecular bone (2–12 MPa) [29], while producing a scaffold with pore diameters large enough to 
enable vascularization and bone ingrowth [30]. By fixing the mass ratio of polymer, bioceramic, and 
porogen during the fabrication process, we discovered that the bioceramic identity strongly contributes 
to the resulting pore structure and porosity, likely due to interactions between the ceramic and polymer 
during the gas foaming/particulate leaching process. Pores of composite scaffolds exhibited a more 
irregular geometry than pores within control scaffolds. PLG control scaffolds were more than 90% 
porous, while the addition of HA and TCP reduced composite scaffold porosity to approximately 80%. 
The addition of BG further reduced scaffold porosity without visible differences in pore structure, 
suggesting that BG may occlude the micropores within the substrate, thus potentially limiting the 
success of this implant from the standpoint of diffusional transport to entrapped cells. Indeed, 
composite scaffolds containing BG possessed the smallest pore diameter, thus supporting the 
hypothesis that the ceramic is not fully embedded in the polymer. The decreased porosity of BG-PLG 
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scaffolds may relate to the significantly increased particulate diameters used compared to HA and 
TCP. However, we aimed to fabricate composite scaffolds from commercially available bioceramics. 
Thus, the effect of nanosized BG incorporated into composite scaffolds on osteogenic response 
justifies further examination. 
While scaffold porosity is an important factor relating to vascularization and nutrient transport, 
other factors may contribute to the success of the implant and the cellular response including substrate 
stiffness and exposure of ceramic from polymer. These two phenomena are likely linked due to the 
inherent hydrophilicity of most ceramic materials and hydrophobicity of most polymers. The 
incorporation of bioceramics into polymer composites increased the compressive strength of all 
materials. Although increases in substrate stiffness are commonly reported with ceramic-polymer 
composites, the relatively small increase in compressive modulus may be attributed to the lack of 
interfacial bonding strength between the ceramic phase and the polymer matrix [31]. Additionally, 
increases in substrate stiffness are likely due to a reduction in void space within the construct, as well 
as the ability of embedded material to support compressive load. In agreement with previous studies 
from our laboratory and others [14,18,32], we observed a corresponding increase in compressive 
modulus with decreasing porosity for both HA- and TCP-loaded scaffolds. However, BG-PLG 
scaffolds exhibited a lower compressive modulus than the other composite scaffolds while producing 
an even lower porosity. These data suggest that BG is not embedded within the polymer during gas 
foaming as effectively as the other bioceramics, and this may enhance osteogenesis by increasing the 
availability of osteostimulative ions resulting from BG dissolution to surrounding cells [33].  
These data suggest that other factors beyond bulk mechanical properties may contribute to the 
cellular response. The exposure of ceramic resulting from differences in partitioning from the polymer, 
as well as ionic dissolution from the ceramic filler, may have a profound effect on the osteogenic 
potential of associated cells. Composites containing HA, which were previously coated with sucrose to 
minimize embedding in the polymer and thus maximize access and availability to surrounding cells, 
demonstrated significant increases in bone formation compared to scaffolds without sucrose-coated 
HA [34]. These data suggest that ceramic exposure is an important aspect to consider when designing 
these materials. Strategies to control interfacial bonding strength, perhaps by alkaline treatment to 
increase roughness and surface area [35], merit further investigation. Previous studies have reported 
the importance of the ionic dissolution products of BG to upregulate osteogenic gene expression in 
osteoblastic cells [36] or enhance local angiogenesis [23,37], and BG dissolves more rapidly than other 
bioceramics. Furthermore, the presence of different fillers may contribute to the degradation behavior 
of the ceramics and alter the local pH around the scaffold, hence contributing to the interaction of the 
material with the osteoblastic cells.  
Biomaterials used for matrix construction possess distinct affinities for plasma proteins, which 
contribute to cellular adhesion and construct integration with surrounding bone [38]. Like many other 
synthetic polymers, PLG is hydrophobic, and the incorporation of bioceramic produced more hydrophilic 
scaffolds. As shown in earlier work from our laboratory and others [18], nanosized HA was uniformly 
incorporated into porous scaffolds using the gas foaming process, and we observed similar distribution 
for TCP and BG. Previous studies report greater hydrophilicity of HA versus TCP when measuring 
contact angles of water on homogeneous ceramics [39]. Trypan blue staining demonstrated that 
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composite scaffolds have a substantial portion of exposed bioceramic from the polymer, which may 
provide binding sites for plasma proteins or cells when implanted or used as a cell delivery vehicle.  
Osteoblasts play a critical role in the maintenance of mineral deposition and calcium-phosphate 
homeostasis. Bioceramics nucleate cell-secreted calcium and promote the formation of a mineralized 
microenvironment that directs subsequent osteoblast activity. Compared to osteoblasts on PLG control 
scaffolds, cells on HA- and TCP-PLG substrates exhibited lower expression of RUNX2 and COL1A1 at 
both time points. We have observed similar trends in osteogenic gene expression for human 
mesenchymal stem cells when cultured on PLG control substrates or PLG scaffolds coated with  
bone-like mineral, yet we observed increased ALP activity and calcium deposition [22]. This 
unexpected reduction may be due to a number of reasons. In the presence of increased concentrations 
of bone-like minerals, cells may alter their osteogenic program, thus shifting the temporal sequence of 
gene expression. Alternatively, proteins from the surrounding media may adsorb differentially to HA 
and TCP, thus initiating alternate integrin engagement and downstream signaling pathways that act 
alongside, or independent of RUNX2 to modulate osteogenesis. In these studies, osteoblasts cultured 
on HA-PLG scaffolds demonstrated lower ALP activity and lower expression of RUNX2, COL1A1, 
and SPARC, signifying a less potent osteogenic response compared to other materials. Conversely, 
osteoblasts cultured on BG-PLG scaffolds uniformly exhibited a greater osteogenic response after  
21 days of culture. BG degrades much faster than HA and TCP, and bioactive glasses activate 
numerous cellular pathways including osteogenic differentiation, cellular proliferation and metabolism 
by stimulating neighboring cells with their ionic degradation products [33]. In addition, 45S5® 
Bioglass contains silica, a constituent that is lacking from the HA and TCP employed in this study. In 
previous studies characterizing the response of human osteoblasts seeded on silica surfaces without the 
interference of other ions present in glass ceramics, there were no apparent differences in cell number, 
metabolic activity, or ALP activity, yet nodule formation was accelerated on silica surfaces [40].  
The importance of silica is confirmed in other studies demonstrating significant increases in ALP 
activity and type I collagen production by osteoblasts exposed to bioactive glasses with 46.1 mol% 
silica content (45S5) than cells exposed to bioactive glasses with 60 or 80 mol% silica (58S and 77S, 
respectively) [41]. 
4. Conclusions  
The results of this study demonstrate that bioceramic selection plays an important role in the resulting 
biophysical properties and osteogenic potential of 3D composite scaffolds for use in bone tissue 
engineering. Using a fabrication process that avoids excessive heat or harsh organic solvents, we produced 
macroporous, biodegradable composite materials using three widely used bioceramics with compressive 
moduli on the order of trabecular bone and possessing osteogenic potential. Furthermore, these 
data suggest that the physical properties and osteogenic response can be further tailored by increasing  
polymer-ceramic interactions or through incorporating other materials such as bioactive glasses with 
increased silica content. These observations and principles may be valuable to tailor the properties of the 
implant to specific bone defects or develop alternative in vitro models of bone formation.  
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